The recent magpie trail demonstrated that magnesium sulphate compared to a placebo reduced the risk of fitting by half, among 10,000 women in 33 countries worldwide. Selective magnesium sulfate prophylaxis for the prevention. Most women with severe maternal hypertension have preeclampsia and will be given mgso 4 based on the magnesium sulfate for prevention of eclampsia magpie trial. Magnesium sulfate is the drug of choice for prevention of seizures as part of comprehensive management of the disease.
Based on high quality evidence, binational clinical practice guidelines recommend the use of antenatal magnesium sulphate for women at risk of imminent, preterm birth at less than 30 weeks for the neuroprotection of their preterm infants the. Between 1998 and 2001, 10 141 women were recruited to the magpie trial at 175 hospitals in 33 countries. As in many other low and middleincome countries lmic. Balancing the scales expanding treatment for pregnant women with lifethreatening hypertensive conditions in developing countries a report on barriers. The results of the magpie trial june 1, p 18771 confirm claims that magnesium sulphate given during labour and for at least 24 h post partum will reduce the risk of seizures in women with severe preeclampsia or imminent eclampsia. The panel issued a tentative safety assessment for public comment with the conclusion that magnesium sulfate is. At the 18month corrected age, the longterm effects of magnesium sulfate on fetuses were evaluated. Magnesium sulphate to prevent cerebral palsy following. Stop magnesium sulfate infusionadministration fetal assessment administer calcium gluconate 10 ml of 10% solution over 10. The canadian institutes of health research provided funding for the magcp magnesium sulphate for fetal neuroprotection project, of which this analysis is a component. Recruitment for magenta was completed in february 2018. A randomized, controlled trial of magnesium sulfate for. Despite the compelling evidence for the effectiveness of magnesium sulfate, concern has been expressed about its safety and potential.
This is not a list of all drugs or health problems that interact with magnesium sulfate injection. Magnesium sulphate neuroprotection of preterm infants. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. Intrapartum magnesium sulfate and need for intensive delivery. Severe preeclampsia is a common cause of maternal death, leading to approximately 50,000 maternal deaths per year. These conflicting results may be explained by the timing of treatment. However, since the magpie trials, there is general international consensus that magnesium sulfate is the drug of choice to treat eclampsia. Full text perception of midwives towards magnesium sulfate.
Expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension between 24 and 34 weeks gestation. The use of magnesium sulphate for the treatment of severe. The panel noted that salts of sulfuric acid, such as sodium sulfate, can be irritating to the skin so cosmetic products containing magnesium sulfate should be formulated to be nonirritating. Magnesium sulfate versus placebo or no anticonvulsant six rcts 11 444 women, including the large multicentre magpie trial 7 involving 10 141 participants, provided the evidence for this comparison. The incidence of eclampsia in the united states has been reported to be 1 in 3,250 births.
Magnesium sulfate for prevention of eclampsia magpie the magpie trial, a large international trial to evaluate the impact of antenatal mgso 4 administration in the prevention of eclampsia, included 10,141 women with preeclampsia between july 1998 and november 2001. Effect of magnesium sulfate exposure on term neonates. In this multicenter, placebocontrolled, randomized trial of intravenous magnesium sulfate in women at imminent risk for delivery between 24 and 31 weeks of gestation, magnesium sulfate did not sig. Alternative regimens of magnesium sulfate for treatment of. Assessment at 23 years after delivery for women recruited to the magpie trial recruitment in 19982001, isrctn 86938761, which compared magnesium sulphate with placebo for preeclampsia. Magnesium sulfate mgso 4 is the anticonvulsant of choice for eclampsia prophylaxis and treatment. Preeclampsiaeclampsia is one of the most common causes of maternal and perinatal morbidity and mortality in low and middle income countries. Frontiers fetal neuroprotection by magnesium sulfate. Magnesium administered prior to preterm delivery crosses over to the foetal circulation and acts via several pathways to reduce perinatal neuronal damage. Follow promptly with 10 g of 50% mgso 4 solution, 5 g in each buttock via deep im injections with 1 ml of 2% lignocaine in the same syringe. Safety assessment of magnesium sulfate as used in cosmetics. The current status of magnesium sulfate mgso 4 for fetal neuroprotection is an analogous situation.
Magnesium sulphate given before verypreterm birth to protect infant brain. Oct 31, 2019 if you are allergic to magnesium sulfate injection. Magnesium sulfate chemical and technical assessment revised. The aim of this study was to assess longterm effects for women following the use of magnesium sulphate for preeclampsia. Analysis of prophylaxis strategies in the united states determined that universal prophylaxis with mgso 4. Outcome for women at 2 years magpie trial followup study collaborative. Alternative magnesium sulfate dosing regimens for women. Generating an epub file may take a long time, please be patient. Ii rct n 10, 141 the antenatal magnesium sulphate for neuroprotection guideline development panel antenatal magnesium sulphate prior to preterm birth for neuroprotection of the fetus, infant and child. Magnesium sulfate for the prevention of cerebral palsy. Magnesium sulphate and other anticonvulsants for women with pre. Capitals indicate lifethreatening, underlines indicate most frequent.
Women 9996 with preeclampsia from the magpie trial. Pdf is there a benefit to continue magnesium sulphate. A threeyear study called the magpie trials was launched in. Wall street business magnate stephen chu, winner of the strathmores whos who registry honoring the most successful business tycoons in the world, says the demolisher betting system lived up exactly to its billing. In these trials, magnesium sulfate was compared with diazepam, phenytoin, or a lytic cocktail. Lower doses and preoperative initiation of magnesium achieved the greatest reduction in postoperative atrial fibrillation. Tell your doctor about the allergy and what signs you had. Increasing uptake and correct administration of magnesium sulfate for management of severe preeclampsia and eclampsia susheela m. Metaanalysis of the trial data indicates that antenatal magnesium. Introduction purpose this report summarizes the activities and results from a focused intervention to strengthen the use of evidencebased practice for management of severe preeclampsia and eclampsia spee with magnesium sulphate in 22 health facilities across nepal. Australian injectable drugs handbook, 6th edition, society of hospital pharmacists of australia 2014. Intrapartum magnesium sulfate and need for intensive. Do women with preeclampsia, and their babies, benefit. Magnesium sulfate was evaluated by the committee at its 63rd meeting.
If the woman had recently received a loading dose of magnesium sulphate at a referring hospital, she could be randomised and the trial treatment loading dose omitted. The outstanding information on functional uses other than nutrient supplement as well as information on commercial use of anhydrous magnesium sulfate and magnesium sulfate was requested for evaluation by the 68th jecfa meeting. Magnesium sulphate more than halved the risk of eclampsia, and probably reduced the risk of. Improper use of magnesium sulfate has been reported globally. Therefore, actionable findings for improving magnesium sulfate use are needed. Request pdf do women with preeclampsia, and their babies, benefit from magnesium sulphate. Magnesium sulfate injection, usp 50% is a sterile, nonpyrogenic, concentrated solution of magnesium sulfate heptahydrate in water for injection. Antenatal magnesium sulfate for neuroprotective effects in. Magnesium sulphate anticonvulsant therapy aims to prevent and treat eclamptic seizures background magnesium sulphate mgs0 4 more than halves the risk for eclampsia, and probably reduces the risk of maternal death. Magnesium sulphate more than halved the risk of eclampsia, and probably reduced the risk of maternal death. The most concerning major side effect of magnesium sulfate is respiratory depression. Prophylactic magnesium sulphate in severe preeclampsia. Magnesium sulfate is an anticonvulsant drug recommended by.
Magnesium sulfate therapy in preeclampsia and eclampsia. Treatment duration ranged from 10 to 144 hours, and the total amount of magnesium administered ranged from 7 to 110 mmol. Magnesium sulphate to prevent cerebral palsy following preterm birth 1. If convulsions recur after 15 minutes, give 2 g magnesium sulfate 50% solution iv over 5 minutes. Magnesium sulphate mgso4 was first introduced to control convulsions in 1925, but it was the collaborative eclampsia trial in 1995 that confirmed the efficacy of mgso4 in the treatment of severe preeclampsia and eclampsia. Eclampsia is the third major cause of maternal mortality in pakistan. Safe practices to decrease the inherent risk of high alert. However, trials comparing magnesium sulphate with alternative agents for tocolysis of preterm labour show an increase. Who recommendation on the use of magnesium sulfate for.
The neuroprotective effect of antenatal magnesium sulfate on very preterm infants has been demonstrated in goodquality randomised controlled trials and metaanalyses. Who recommendation on magnesium sulfate for the prevention. The magpie trial is comparing magnesium sulphate with placebo for treatment of women with preeclampsia. The significance of this is unclear, although neonatal magnesium levels are known to correlate with maternal dosing of magnesium 41, 42 and exposure to magnesium sulfate is associated with nicu admission in a dose. The iv regimen required six ampoules of trial treatment 58 ml, and the im regimen eight ampoules 78 ml.
Increasing uptake and correct administration of magnesium. Strengthening the use of magnesium sulphate for management of spee 3 i. Jun 01, 2002 do women with preeclampsia, and their babies, benefit from magnesium sulphate. Magnesium treatment for neuroprotection in ischemic diseases. Background the prevalence of preterm birth is increasing. It is administered by the intravenous iv or intramuscular im routes as an electrolyte replenisher or anticonvulsant. Eclampsia, the occurrence of seizures superimposed on preeclampsia, is rare but associated with a far worse outcome than pre. Magnesium sulfate for the treatment of eclampsia stroke. The use of magnesium sulphate for the treatment of severe pre.
Antenatal magnesium sulfate for fetal neuroprotection. Evidence supports the use of magnesium sulfate mgso4 as the first line treatment option for severe preeclampsia and eclampsia. Therapy with both magnesium sulfate and nifedipine does not. Whereas magnesium has shown neuroprotective properties in animal models of global and focal cerebral ischemia, this effect could not be reproduced in a large human stroke trial. Altman d, carroli g, duley l, farrell b, moodley j, neilson j, smith d. Two randomized control trials provided the scientific evidence needed to promote mgso 4 as the anticonvulsant of choice for the treatment of severe preeclampsia and eclampsia. Magnesium sulfate is the drug of choice for prevention of seizures as part of. Optimizing treatment for the prevention of preeclampsia. The panel concluded that magnesium sulfate is safe in the present practices of use and concentration in cosmetics, when formulated to be nonirritating.
Women allocated magnesium sulphate had a 58% lower risk of eclampsia 95% ci 4071 than those allocated placebo 40. Thirtythree countries participating in the magnesium sulphate for prevention of eclampsia magpie trial. In the magnesium sulphate for prevention of eclampsia magpie trial, researchers randomized women with preeclampsia in labor to receive magnesium sulfate or placebo and assessed rates of eclampsia. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion thomas easterling1, mary hebert2, hillary bracken3, emad darwish4, mohamed cherine ramadan5. Magnesium sulfate an overview sciencedirect topics. Do women with preeclampsia, and their babies, benefit from.
Magnesium sulfate mgso 4 has been used throughout the 20th century for prevention of eclamptic seizures, 1,2 and it continues to be used extensively. Do women with preeclampsia, and their babies, benefit from magnesium sulphate. Overall, 9024 children were included in the analysis of outcome at discharge from hospital. Magnesium sulphate at 30 to 34 weeks gestational age. Dr l duley, magpie trial office, nuffield department of medicine, level 5, john radcliffe hospital, headington, oxford ox3 9du, uk. Findings demonstrate that magnesium sulfate meaningfully reduces the risk of eclamptic seizures among women with preeclampsia. Outcome and hospital resource use data were available for the trial period from the magpie trial. Specifically, although the multicenter european magpie trial demonstrated clear benefits of magnesium sulfate for eclampsia prophylaxis in women with severe gestational hypertension, its use for those with mild hypertension remains controversial.
Two timelines of milestones in maternal health 198520. Globally, magnesium sulfate mgso 4 has been recognized as the drug of choice for preventing and controlling fits among women with severe preeclampsia and eclampsia, respectively. Design assessment at 18 months of age for children whose mothers w. Severe preeclampsia and eclampsia are rare but serious complications of pregnancy that threaten the lives of mothers during childbirth. Even in the magpie trial there was diversity in the use of magnesium sulphate depending on the various trial centres. The use of magnesium sulphate for the treatment of eclampsia. Give magnesium sulfate 20% solution, 4 g iv over 5 minutes 2. A randomized controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe preeclampsia. Magnesium sulfate reproductive health supplies coalition. There did not appear to be any substantive harmful. Efficacy and safety of magnesium sulphate mgso4 in the treatment of eclampsia article pdf available in journal of the indian medical association 1097. Results showed that magnesium administration significantly decreased the percentage of patients developing postoperative atrial fibrillation. Altman d, carroli g, duley l, farrell b, moodley j, neilson j, et al.
The magpie trial was primarily designed to determine the maternal neurological effects of magnesium, but also reported on neonatal outcomes. Preeclampsia is a multisystem, progressive disorder characterized by the new onset of hypertension and proteinuria or hypertension and endorgan dysfunction with or without proteinuria in the last half of pregnancy. The magpie trial magnesium sulphate mgso 4 was first introduced to control convulsions in 1925, but it was the collaborative eclampsia trial in 1995 that confirmed the efficacy of mgso 4 in the treatment of severe preeclampsia and eclampsia. A randomised trial comparing magnesium sulphate with placebo for preeclampsia. In this multicenter, placebocontrolled, randomized trial of intravenous magnesium sulfate in women at imminent risk for delivery between 24 and 31 weeks of gestation, magnesium sulfate. However, this trend was not found in other key studies including the magpie trial, 17, 44, 45. We did not specify a priori a dose of magnesium, because of a paucity of evidence on doseresponse mechanics, or a method of blinding, or a specific spirometric outcome. Pdf efficacy and safety of magnesium sulphate mgso4 in. Costeffectiveness of prophylactic magnesium sulphate for. The study of magnesium sulphate vs diazepam in eclampsia. Setting neonatal intensive care units in the canadian neonatal network.
The trial also called magpie trial was a randomized, placebo. Magnesium sulfate is the primary medication used in the prevention and management of eclamptic seizures and exerts its effect by depressing the central nervous system. Manual for the bayley scales of infant development. The drug liquid format is encapsulated in hospiras ansyr singledose. The magpie trial compared magnesium sulphate with placebo for women with preeclampsia. Various studies have confirmed the efficacy of magnesium sulfate in reducing. Magnesium sulphate for eclampsia or eclampsia prophylaxis. Doses of magnesium sulphate used in the prophylactic treatment were similar to those used in the treatment of eclampsia. However, the gdg felt that administering magnesium sulfate at any time from immediately prior to birth, up to 24 hours prior to anticipated birth is appropriate. One small trial 36 women compared magnesium sulfate with isosorbide, and another trial 33 women compared magnesium chloride with methyldopa. The median time from 35 magnesium sulfate administration to birth was reported in only two of the trials that generated the evidence 1 hour 38 minutes and 3. Magnesium sulfate given for seizure prophylaxis 4 6 g loading dose12 g per hour maintenance dose magpie trial established 1 gmhr dose effective controversy over whether mgso4 is needed in mild preeclampsia when closely monitored treatment usually continues for 24 hours after birth. Clinical practice guideline hypertension in pregnancy.